QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

EHC

QT64Encompass Health Corporation
NYSE·Healthcare·Medical - Care Facilities·USA
Latest market price
98.03
+0.14+0.14%
OverviewShort InterestFilings
EHCQT64Encompass Health Corporation·NYSE
OverviewShort InterestFilings
98.03+0.14%
TA
Loading chart...
Screen all →
HCA-3.35%$375.17THC-3.32%$172.57DVA-1.27%$207.91SOLV+1.17%$75.43FMS+0.08%$23.59ENSG-1.41%$153.65UHS-0.06%$141.17CHE+0.06%$436.27
Snapshot
Index-P/E15.94EPS (ttm)5.99
Insider Own2.00%
Shs Outstand99.20M
Perf Week-4.25%
Market Cap9.71BForward P/E14.99EPS next Y6.54Insider Trans-0.14%Shs Float-Perf Month-6.42%
Enterprise Value12.34BPEG0.67EPS next Q1.48Inst Own-Short Float-Perf Quarter0.14%
Income608.85MP/S1.60EPS this Y0.31%Inst Trans-Short Ratio-Perf Half Y-9.24%
Sales6.07BP/B3.85EPS next Y8.81%ROA8.33%Short Interest-Perf YTD-7.64%
Book/sh33.94P/C8.09EPS next 5Y11.18%ROE25.35%52W High127.99 -23.41%Perf Year-17.75%
Cash/sh2.03P/FCF20.91EPS past 3/5Y-ROIC13.26%52W Low92.77 5.67%Perf 3Y-
Dividend Est.0.76 (0.78%)EV/EBITDA8.44Sales past 3/5Y10.92% 10.73%Gross Margin58.82%Volatility1.86% 1.93%Perf 5Y-
Dividend TTM0.74 (0.75%)EV/Sales2.03EPS Y/Y TTM27.58%Oper. Margin17.93%ATR (14)2.99Perf 10Y-
Dividend Ex-DateJul 01, 2026Quick Ratio1.17Sales Y/Y TTM12.94%Profit Margin10.04%RSI (14)38.75Recom2.19
Dividend Gr. 3/5Y-4.46% -4.71%Current Ratio1.17EPS Q/Q16.79%SMA20-4.30%Beta0.24Target Price146.00
Payout12.05%Debt/Eq1.11Sales Q/Q9.07%SMA50-5.83%Rel Volume1.74Prev Close97.89
Employees28,572LT Debt/Eq0.81EarningsAug 03SMA200-10.47%Avg Volume906.07KPrice98.03
IPO DateSep 24, 1986Option/ShortYes / YesEPS/Sales Surpr.5.96% 1.21%Net Debt/EBITDA1.80Volume1,576,083Change0.14%
Analyst Ratings
DateActionAnalystRatingTarget
May-22-26ReiteratedLeerink Partners$152
May-05-26ReiteratedBarclaysOverweight$153 → $140
Feb-06-26ReiteratedBarclaysOverweight$150 → $153
Oct-30-25ReiteratedBarclaysOverweight$101 → $150
Oct-02-25ReiteratedUBSBuy$110 → $150
Aug-14-25ReiteratedTruist Financial$135 → $140
Apr-28-25ReiteratedRBC CapitalOutperform$105 → $125
Sep-26-24ReiteratedRBC CapitalOutperform$95 → $105
Sep-25-24ReiteratedUBSBuy$110
May-22-24ReiteratedRBC CapitalOutperform$85 → $95
Latest News
Jun-17-26
Jun-17-2603:17PM
DaVita Expands Specialized Care Beyond Acute Settings Through IKCYahoo
Jun-15-26
Jun-15-2606:30PM
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026?Yahoo
01:50PM
Healthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitYahoo
Jun-11-26
Jun-11-2611:04PM
Is HCA Healthcare Stock A Trap Or A Missed Opportunity?Yahoo
Jun-10-26
Jun-10-2606:13PM
EHC Expands Georgia Footprint With New 40-Bed Rehab HospitalYahoo
03:13PM
3 Reasons EHC is Risky and 1 Stock to Buy InsteadYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue6,0685,9355,373
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,4992543,140
Gross Profit3,5695,6812,233
Selling, General and Administrative Excl. Other1,0723,411267
Research and Development
000
Other Operating Expense1,4091,2171,102
Operating Income1,0881,053865
Interest Expense123123137
Unusual Expense
———
Non-Operating Income (Expense)-38-23-22
Net Income Before Taxes1,004953750
Income Taxes207193150
Consolidated Net Income610566456
Net Income From Continuing Operations795760599
Net Income610566456
EPS (Recurring)6.085.624.53
EPS (Basic, Before Extraordinaries)6.085.624.53
EPS (Diluted)5.995.544.46
EBITDA1,4621,4041,187
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio16.3719.16—
Price To Sales Ratio1.601.81—
Gross Margin58.8295.7241.56
Operating Margin17.9317.7416.10
Net Margin10.059.548.49
Shares Outstanding99101100
Market Capitalization9,70510,720—
Operating Lease Expense
———
Insider Trading Volume
$101.70$93.75$85.80$77.84$69.89● Close Price0.00M4.26M8.52M12.79M17.05MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Option Exercise32.9455,3881,824,48097,071May 18 12:00 AM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Sale106.8327,6942,958,55069,377May 18 12:00 AM
Tuer Patrick WilliamEVP, Chief Operating OfficerMay 11 '26Sale104.5668271,31024,755May 12 12:00 AM
Fay EdmundSr. Vice Pres. and TreasurerMar 09 '26Sale107.0011,9371,277,25989,325Mar 10 12:00 AM
Tarr Mark JPresident & CEOFeb 11 '26Sale111.64150,00016,746,689377,070Feb 12 12:00 AM
Tuer Patrick WilliamEVP, Chief Operating OfficerFeb 10 '26Sale107.622,804301,76616,042Feb 10 12:00 AM
Tuer Patrick WilliamEVP, Chief Operating OfficerAug 27 '25Sale123.591,020126,06218,846Aug 27 12:00 AM
Tarr Mark JPresident & CEOMay 20 '25Option Exercise40.10236,7689,494,224645,454May 20 12:00 AM
Tarr Mark JPresident & CEOMay 20 '25Sale121.53118,38414,387,152527,070May 20 12:00 AM
Charbonneau Elissa JoyChief Medical OfficerMay 06 '25Sale116.614,279498,97411,958May 07 12:00 AM
Darby John PatrickEVP, Gen Counsel & SecretaryApr 29 '25Option Exercise35.0620,000701,20089,710Apr 30 12:00 AM
Darby John PatrickEVP, Gen Counsel & SecretaryApr 29 '25Sale114.7910,0001,147,90079,710Apr 30 12:00 AM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerApr 29 '25Option Exercise31.5187,1502,745,980103,910Apr 30 12:00 AM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerApr 29 '25Sale115.1543,5755,017,53760,335Apr 30 12:00 AM
Price Andrew LChief Accounting OfficerFeb 13 '25Sale98.295,042495,57869,164Feb 13 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR